Transcutaneous Electric Nerve Stimulation (TENS) for Vagal Modulation
Functional Gastrointestinal Disorders
About this trial
This is an interventional treatment trial for Functional Gastrointestinal Disorders
Eligibility Criteria
Inclusion Criteria: Female 12 - 18 years old Either diagnosed OR not diagnosed with chronic idiopathic nausea, functional abdominal pain, dyspepsia and/or irritable bowel syndrome. English speaking Exclusion Criteria: Patients who are unable to stand upright during the heart rate variability recording Patients with a known bleeding disorder Patients with swollen, infected, inflamed, or other skin eruptions on outer ear Patients with epilepsy Patients with any implanted cardiac pacemaker or defibrillator Patients with serious arterial circulatory problems in the lower limbs Patients with abdominal or inguinal hernia Patients who are pregnant Any unstable medical condition, such as renal disease, uncontrolled diabetes, etc. Requires new medication during the 4 weeks of the study that may affect the gastrointestinal symptoms, vagal modulation or immune response. Practices over 1 hour of aerobic activity a day Daily practice of abdominal breathing (yoga)
Sites / Locations
- Virginia Commonwealth UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
FGID
Non-FGID
Patients with a FGID
Patients without a FGID